MDxHealth SA (MDXH)
2.70
-0.18
(-6.25%)
USD |
NASDAQ |
May 15, 16:00
2.70
0.00 (0.00%)
After-Hours: 16:47
MDxHealth Profit Margin (Quarterly): -42.91% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -42.91% |
December 31, 2023 | -55.26% |
September 30, 2023 | -51.91% |
June 30, 2023 | -63.46% |
March 31, 2023 | -79.65% |
December 31, 2022 | -96.49% |
Date | Value |
---|---|
September 30, 2022 | -121.1% |
June 30, 2022 | -142.5% |
March 31, 2022 | -135.4% |
December 31, 2021 | -134.4% |
September 30, 2021 | -138.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-142.5%
Minimum
Jun 2022
-42.91%
Maximum
Mar 2024
-96.52%
Average
-96.49%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
Galapagos NV | -- |
UCB SA | -- |
Mithra Pharmaceuticals SA | -- |
Nyxoah SA | -597.2% |
Celyad Oncology SA | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -225.7% |
Return on Assets | -29.34% |
Return on Invested Capital | -74.31% |
Gross Profit Margin (Quarterly) | 60.82% |
Operating Margin (Quarterly) | -33.30% |
Return on Net Operating Assets | -38.78% |